Top compounds associated with response to RP11-286N22.8


Feature Type Standardized
Nominal ANOVA
mRNA etoposide CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.0097 0.8
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC 0.019 0.8
mRNA rigosertib CTRPv2 pan-cancer AAC -0.0087 0.8
mRNA neratinib CTRPv2 pan-cancer AAC 0.0093 0.8
mRNA KU 0060648 CTRPv2 pan-cancer AAC -0.0092 0.8
mRNA clofarabine CTRPv2 pan-cancer AAC 0.0074 0.8
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.008 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0088 0.8
Download CSV